TriMas Co. (NASDAQ:TRS - Get Free Report)'s share price gapped down before the market opened on Monday . The stock had previously closed at $23.98, but opened at $23.17. TriMas shares last traded at $23.16, with a volume of 16,028 shares.
Analyst Ratings Changes
Several equities research analysts have issued reports on the stock. BWS Financial reaffirmed a "buy" rating and set a $40.00 price target on shares of TriMas in a research note on Tuesday, November 5th. StockNews.com upgraded shares of TriMas from a "sell" rating to a "hold" rating in a report on Wednesday, November 13th.
View Our Latest Stock Report on TRS
TriMas Trading Down 4.0 %
The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The business's 50 day moving average price is $25.95 and its 200-day moving average price is $25.61. The firm has a market cap of $934.37 million, a price-to-earnings ratio of 35.98 and a beta of 0.67.
TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.57 by ($0.14). TriMas had a net margin of 2.93% and a return on equity of 9.21%. The company had revenue of $229.36 million for the quarter, compared to analyst estimates of $239.33 million. During the same quarter in the prior year, the firm earned $0.57 EPS. The company's revenue for the quarter was down 2.5% compared to the same quarter last year. Equities analysts expect that TriMas Co. will post 1.69 EPS for the current year.
TriMas Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 12th. Shareholders of record on Tuesday, November 5th were issued a dividend of $0.04 per share. The ex-dividend date of this dividend was Tuesday, November 5th. This represents a $0.16 annualized dividend and a yield of 0.69%. TriMas's payout ratio is presently 25.00%.
Institutional Trading of TriMas
Institutional investors have recently made changes to their positions in the stock. Impax Asset Management Group plc raised its position in shares of TriMas by 216.4% in the third quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company's stock valued at $10,467,000 after purchasing an additional 280,431 shares during the period. Wellington Management Group LLP boosted its holdings in TriMas by 10.7% during the third quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company's stock valued at $66,872,000 after acquiring an additional 252,537 shares during the period. Invenomic Capital Management LP acquired a new stake in shares of TriMas in the third quarter valued at about $3,655,000. Western Standard LLC increased its position in TriMas by 86.6% in the 3rd quarter. Western Standard LLC now owns 169,069 shares of the industrial products company's stock worth $4,316,000 after buying an additional 78,450 shares during the period. Finally, Atom Investors LP boosted its position in shares of TriMas by 62.0% in the third quarter. Atom Investors LP now owns 179,328 shares of the industrial products company's stock valued at $4,578,000 after acquiring an additional 68,608 shares during the period. 99.42% of the stock is currently owned by institutional investors and hedge funds.
About TriMas
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Further Reading
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
